PMV Pharmaceuticals, Inc. (PMVP) has 20 known insider and institutional holders on record. The largest holder is ORBIMED ADVISORS LLC with 4,975,291 shares. Other notable holders include Double Epiphany, LLC and Schroeder Thilo.
Over the last 12 months, insiders have made 18 transactions in PMVP stock — 9 buys (valued at $2.62M) and 6 sells (valued at $2.57M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
PMVP Insider Ownership
Top Holder
ORBIMED ADVISORS LLC
4,975,291 shares
Buys (12 mo)
9
$2.62M value
Sells (12 mo)
6
$2.57M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Orbimed Advisors Llc |
10 Percent Owner |
4,975,291 |
2025-10-27 |
|
| 2 |
Double Epiphany, Llc |
10 Percent Owner |
1,282,026 |
2020-09-24 |
|
| 3 |
Schroeder Thilo |
Director |
1,101,283 |
2021-10-08 |
|
| 4 |
Boxer Capital, Llc |
Officer |
950,000 |
2020-09-29 |
|
| 5 |
Mack David Henry |
President and CEO |
744,960 |
2026-03-09 |
|
| 6 |
Dawson Samantha |
10 Percent Owner |
427,342 |
2020-09-24 |
|
| 7 |
Levine Alison |
10 Percent Owner |
427,342 |
2020-09-24 |
|
| 8 |
Ticktin Robert |
General Counsel & COO |
319,270 |
2026-03-09 |
|
| 9 |
Jalota Deepika |
Chief Development Officer |
303,310 |
2026-03-09 |
|
| 10 |
Carulli Michael |
Chief Financial Officer |
240,000 |
2026-03-09 |
|
| 11 |
Kung Winston |
COO, CFO |
150,000 |
2023-05-15 |
|
| 12 |
Euclidean Capital Llc |
Director |
128,359 |
2021-06-15 |
|
| 13 |
Orbimed Capital Llc |
Director |
109,500 |
2022-03-31 |
|
| 14 |
Orbimed Genesis Gp Llc |
Director |
87,786 |
2022-05-31 |
|
| 15 |
Gallagher Carol Giltner |
Director |
67,500 |
2024-06-10 |
|
| 16 |
Oronsky Arnold L |
10 Percent Owner |
55,555 |
2020-10-02 |
|
| 17 |
Interwest Partners X Lp |
Director |
55,555 |
2020-10-02 |
|
| 18 |
Alland Leila |
Chief Medical Officer |
45,909 |
2023-09-18 |
|
| 19 |
Flowers Kirsten |
Director |
33,500 |
2025-06-09 |
|
| 20 |
Baum Charles M |
Director |
33,500 |
2025-06-09 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-05 |
Carulli Michael |
Chief Financial Officer |
RSU Award |
240,000 |
$1.53 |
$367.2K |
| 2026-03-05 |
Jalota Deepika |
Chief Development Officer |
RSU Award |
303,310 |
$1.53 |
$464.06K |
| 2026-03-05 |
Ticktin Robert |
General Counsel & COO |
RSU Award |
319,270 |
$1.53 |
$488.48K |
| 2026-03-05 |
Mack David Henry |
President and CEO |
RSU Award |
744,960 |
$1.53 |
$1.14M |
| 2025-10-27 |
Mack David Henry |
President and CEO |
Option Exercise (Sell) |
220,643 |
$1.37 |
$302.28K |
| 2025-10-23 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Sell |
1,000,000 |
$1.52 |
$1.52M |
| 2025-09-10 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Sell |
500,000 |
$1.80 |
$900K |
| 2025-07-01 |
Carulli Michael |
Chief Financial Officer |
Informative Sell |
28,249 |
$1.06 |
$30.08K |
| 2025-07-01 |
Jalota Deepika |
Chief Development Officer |
Informative Sell |
33,065 |
$1.06 |
$35.2K |
| 2025-07-01 |
Ticktin Robert |
General Counsel & COO |
Informative Sell |
23,151 |
$1.06 |
$24.65K |
| 2025-07-01 |
Mack David Henry |
President and CEO |
Informative Sell |
58,411 |
$1.06 |
$62.18K |
| 2025-06-05 |
Flowers Kirsten |
Director |
RSU Award |
33,500 |
$0.95 |
$31.83K |
| 2025-06-05 |
Stelzer Laurie |
Director |
RSU Award |
33,500 |
$0.95 |
$31.83K |
| 2025-06-05 |
Heyman Richard A. |
Director |
RSU Award |
33,500 |
$0.95 |
$31.83K |
| 2025-06-05 |
Baum Charles M |
Director |
RSU Award |
33,500 |
$0.95 |
$31.83K |
| 2025-06-05 |
Gallagher Carol Giltner |
Director |
Gift (Given) |
33,500 |
$0.95 |
$31.83K |
| 2025-06-05 |
Levine Arnold J |
Director |
RSU Award |
33,500 |
$0.95 |
$31.83K |
| 2025-04-21 |
Ticktin Robert |
General Counsel & COO |
Unknown |
265,000 |
$1.32 |
$349.8K |
